The Asian Scientist 100
Lu Ke
Institution
Chinese Academy of Sciences
Country
China
Field
Materials Sciences
Lu is the winner of the 2020 Future Science Prize (Physical Science Prize) for discovering and synthesizing a superior nanotwinned structure and gradient nanostructure.
(Photo: Future Science Prize)
AWARDS
- Future Science Prize 2020
Related articles
Researchers Find Key Markers For Drug-Resistant Malaria
An international team of scientists are launching a major study of drug-resistant malaria in Myanmar.
WWF Report Highlights Diversity Loss In Mekong Region
The Greater Mekong risks losing more than a third of its remaining forest cover within the next two decades, warns a new WWF report.
Global Ranking Reveals Innovation Gap In Southeast Asia
A new report on global sustainable innovation and competitiveness raises concerns over the large gap that exists between various nations in the region.
VaxInnate Licenses Recombinant Flu Vaccines To South Korea’s CJ CheilJedang Corp
VaxInnate Corporation has granted CJ CheilJedang Corporation an exclusive license to manufacture, develop, and commercialize its recombinant seasonal and pandemic flu vaccines in South Korea.
Asian Scientist Chats With Prof. Warwick Anderson, CEO Of Australia’s NHMRC
At the recent A*STAR-NHMRC joint symposium, Asian Scientist Magazine sat down for a chat with Prof. Warwick Anderson, CEO of Australia’s National Health and Medical Research Council.
Fab’entech Launches H5N1 Phase I Trial In Singapore
French biotech Fab'entech has launched a Phase I clinical trial in Singapore for its product against the H5N1 Avian Influenza virus.
Pigs In China’s Guangdong Province Infected With Avian Flu
Scientists have made a startling discovery that pigs in China's Guangdong province are infected with avian influenza viruses.
Scientists Identify Gene Variant Linked To Swine Flu In Han Chinese
Researchers have found a genetic variant which explains why Chinese populations may be more vulnerable to swine flu.
Flu Vaccine Candidate May Have Broad Spectrum Efficacy
Researchers have designed a new drug to safeguard against epidemic and pandemic influenza virus strains.